News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
834,027 Results
Type
Article (85785)
Company Profile (649)
Press Release (747593)
Section
Business (232070)
Career Advice (4121)
Deals (39689)
Drug Delivery (124)
Drug Development (90695)
Employer Resources (195)
FDA (17950)
Job Trends (17295)
News (395247)
Policy (39616)
Tag
Academia (2977)
Alliances (56564)
Alzheimer's disease (1401)
Antibody-drug conjugate (ADC) (111)
Approvals (17930)
Artificial intelligence (182)
Bankruptcy (399)
Best Places to Work (12511)
Biotechnology (447)
Breast cancer (187)
Cancer (1541)
Career advice (3523)
CAR-T (130)
Cell therapy (376)
Clinical research (72157)
Collaboration (625)
Compensation (313)
COVID-19 (2808)
C-suite (150)
Data (1393)
Diabetes (151)
Diagnostics (6700)
Earnings (94481)
Employer resources (166)
Events (127271)
Executive appointments (482)
FDA (18657)
Funding (522)
Gene therapy (262)
GLP-1 (685)
Government (5051)
Healthcare (20710)
Infectious disease (2899)
Inflammatory bowel disease (134)
Interviews (810)
IPO (17657)
Job creations (5182)
Job search strategy (2859)
Layoffs (510)
Legal (10038)
Lung cancer (234)
Manufacturing (225)
Medical device (14271)
Medtech (14276)
Mergers & acquisitions (22169)
Metabolic disorders (487)
Neuroscience (1784)
NextGen: Class of 2025 (7661)
Non-profit (5053)
Northern California (1847)
Obesity (266)
Opinion (259)
Patents (142)
People (64501)
Pharmaceutical (131)
Phase I (22284)
Phase II (31377)
Phase III (23581)
Pipeline (638)
Postmarket research (3541)
Preclinical (9997)
Radiopharmaceuticals (247)
Rare diseases (305)
Real estate (7375)
Regulatory (26139)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1575)
Startups (4277)
United States (16258)
Vaccines (668)
Weight loss (205)
Date
Today (9)
Last 7 days (502)
Last 30 days (2061)
Last 365 days (32025)
2025 (3674)
2024 (34031)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1262)
Arizona (226)
Asia (49549)
Australia (8749)
California (4212)
Canada (1368)
China (373)
Colorado (136)
Connecticut (180)
Europe (113372)
Florida (509)
Georgia (113)
Illinois (397)
Indiana (228)
Maryland (715)
Massachusetts (3375)
Michigan (169)
Minnesota (277)
New Jersey (1199)
New York (1179)
North Carolina (894)
Northern California (1847)
Ohio (141)
Pennsylvania (913)
South America (1646)
Southern California (1575)
Texas (554)
Washington State (445)
834,027 Results for "bio techne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES - May 31, 2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences.
May 31, 2024
·
1 min read
Business
Bio-Techne Releases Third Quarter Fiscal 2024 Results
Bio-Techne Corporation reported its financial results for the third quarter ending March 31, 2024.
May 1, 2024
·
23 min read
BioMidwest
Bio-Techne Declares Dividend - May 01, 2024
Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2024.
May 1, 2024
·
2 min read
Business
Bio-Techne Appoints Dr. Judith Klimovsky to Board of Directors
Bio-Techne Corporation announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company’s Board of Directors, April 24, 2024.
April 30, 2024
·
1 min read
Business
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
Bio-Techne Corporation is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers.
April 29, 2024
·
4 min read
BioMidwest
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 , at 8:40 a.m. CDT.
May 23, 2024
·
1 min read
BioMidwest
Bio-Techne to Highlight Multiple Applications of the MauriceFlex™ System at the Annual ASMS Conference
Bio-Techne Corporation will showcase multiple applications of its recently launched MauriceFlex™ System at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics, taking place June 2nd-6th in Anaheim, California.
May 30, 2024
·
3 min read
BioMidwest
Bio-Techne Surpasses 10,000 Peer-Reviewed Publications Citing RNAscope Technology
Bio-Techne Corporation announced that Advanced Cell Diagnostics, part of Bio-Techne’s Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and application of RNAscope™ ISH technology.
April 8, 2024
·
2 min read
BioMidwest
Bio-Techne to Present at the BofA Securities Health Care Conference 2024
Bio-Techne Corporation announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT.
May 8, 2024
·
1 min read
BioMidwest
Bio-Techne and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay
Bio-Techne Corporation and Novomol-Dx, a molecular diagnostics company, are pleased to announce the development of Bio-Marker Pathfinder, a first of its kind ocular biomarker kit, as a point-of-care application.
April 26, 2024
·
3 min read
1 of 83,403
Next
